These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31693657)

  • 1. Prediction of PD-L1 inhibition effects for HIV-infected individuals.
    Zheltkova V; Argilaguet J; Peligero C; Bocharov G; Meyerhans A
    PLoS Comput Biol; 2019 Nov; 15(11):e1007401. PubMed ID: 31693657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals.
    Rosignoli G; Lim CH; Bower M; Gotch F; Imami N
    Clin Exp Immunol; 2009 Jul; 157(1):90-7. PubMed ID: 19659774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions.
    Garcia-Bates TM; Palma ML; Shen C; Gambotto A; Macatangay BJC; Ferris RL; Rinaldo CR; Mailliard RB
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory B cells inhibit cytotoxic T lymphocyte (CTL) activity and elimination of infected CD4 T cells after in vitro reactivation of HIV latent reservoirs.
    Siewe B; Wallace J; Rygielski S; Stapleton JT; Martin J; Deeks SG; Landay A
    PLoS One; 2014; 9(4):e92934. PubMed ID: 24739950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
    Lubaki NM; Shepherd ME; Brookmeyer RS; Hon H; Quinn TC; Kashamuka M; Johnson M; Gottle R; Devers J; Lederman HM; Bollinger RC
    J Acquir Immune Defic Syndr; 1999 Sep; 22(1):19-30. PubMed ID: 10534143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of the CD8
    Li J; Huang HH; Tu B; Zhou MJ; Hu W; Fu YL; Li XY; Yang T; Song JW; Fan X; Jiao YM; Xu RN; Zhang JY; Zhou CB; Yuan JH; Zhen C; Shi M; Wang FS; Zhang C
    Front Immunol; 2021; 12():687296. PubMed ID: 34177939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions.
    Porichis F; Hart MG; Zupkosky J; Barblu L; Kwon DS; McMullen A; Brennan T; Ahmed R; Freeman GJ; Kavanagh DG; Kaufmann DE
    J Virol; 2014 Mar; 88(5):2508-18. PubMed ID: 24352453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characterization of HIV-1 Gag-specific proliferative T cell responses in Chinese HIV-1 infected patients].
    Wang Q; Shang H; Wang YN; Zhang ZN; Jiang YJ
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3099-103. PubMed ID: 17313759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of CD31 expression in CD4+ and CD8+T cell subpopulations in chronic untreated HIV infection.
    Briceño O; Peralta-Prado A; Garrido-Rodríguez D; Romero-Mora K; Chávez-Torres M; de la Barrera CA; Reyes-Terán G; Ávila-Ríos S
    Immunol Lett; 2021 Jul; 235():22-31. PubMed ID: 33852965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.
    Pettersen FO; Taskén K; Kvale D
    Clin Exp Immunol; 2010 Aug; 161(2):315-23. PubMed ID: 20491784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 replication, immune activation, and circulating cytotoxic T cells against uninfected CD4+ T cells.
    Kottilil S; Gamberg J; Bowmer I; Trahey J; Howley C; Gallant M; Grant M
    J Clin Immunol; 2000 May; 20(3):175-86. PubMed ID: 10941825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Proliferation Capacity of Gag-C-Specific Naive and Memory CD4+ and CD8+ T Lymphocytes in Rapid, Viremic Slow, and Slow Progressors During Human Immunodeficiency Virus Infection.
    Negi N; Mojumdar K; Singh R; Sharma A; Das BK; Sreenivas V; Vajpayee M
    Viral Immunol; 2018 Sep; 31(7):513-524. PubMed ID: 30156469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-1/PD-L1 blockade can enhance HIV-1 Gag-specific T cell immunity elicited by dendritic cell-directed lentiviral vaccines.
    Dai B; Xiao L; Bryson PD; Fang J; Wang P
    Mol Ther; 2012 Sep; 20(9):1800-9. PubMed ID: 22588271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype.
    Sáez-Cirión A; Lacabaratz C; Lambotte O; Versmisse P; Urrutia A; Boufassa F; Barré-Sinoussi F; Delfraissy JF; Sinet M; Pancino G; Venet A;
    Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6776-81. PubMed ID: 17428922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors related to loss of HIV-specific cytotoxic T lymphocyte activity.
    Gamberg J; Barrett L; Bowmer MI; Howley C; Grant M
    AIDS; 2004 Mar; 18(4):597-604. PubMed ID: 15090764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons.
    Bernard NF; Pederson K; Chung F; Ouellet L; Wainberg MA; Tsoukas CM
    AIDS; 1998 Nov; 12(16):2125-39. PubMed ID: 9833853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
    Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8(+) T cells from HIV-1-infected individuals.
    Breton G; Yassine-Diab B; Cohn L; Boulassel MR; Routy JP; Sékaly RP; Steinman RM
    J Clin Immunol; 2009 Sep; 29(5):637-45. PubMed ID: 19562472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection.
    Chew GM; Fujita T; Webb GM; Burwitz BJ; Wu HL; Reed JS; Hammond KB; Clayton KL; Ishii N; Abdel-Mohsen M; Liegler T; Mitchell BI; Hecht FM; Ostrowski M; Shikuma CM; Hansen SG; Maurer M; Korman AJ; Deeks SG; Sacha JB; Ndhlovu LC
    PLoS Pathog; 2016 Jan; 12(1):e1005349. PubMed ID: 26741490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8⁺ T cell function in vitro.
    Siewe B; Stapleton JT; Martinson J; Keshavarzian A; Kazmi N; Demarais PM; French AL; Landay A
    J Leukoc Biol; 2013 May; 93(5):811-8. PubMed ID: 23434518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.